SLC5A2 and diabetes mellitus: Supporting this observation, a recent Japanese case report details the case of a 59-year-old patient with refractory ascites due to decompensated liver cirrhosis who experienced marked ascites reduction following SGLT-2 inhibitor initiation for uncontrolled diabetes.16